Phase 2 Myoma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT01799538
Recruiting
Phase 2
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
Stage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8Renal Cell Carcinoma+3 more
National Cancer Institute (NCI)65 enrolled13 locationsNCT04981509
Recruiting
Phase 2
Effects of Simvastatin on Uterine Leiomyoma Size
LeiomyomaFibroid UterusFibroid Tumor+2 more
Johns Hopkins University60 enrolled1 locationNCT03400826
Completed
Phase 2
Comparison of analgesic efficacy of intravenous paracetamol and intravenous dexketoprofen trometamol in multimodal analgesia after hysterectomy
Treating pain which was caused by hysterectomy operationIllnesses which can be treated by performing hysterectomy(abnormal menstrual bleeding, endometriosis, myomas, adenomiyosis)
Hulya Basar60 enrolled1 locationACTRN12613000435785
Recruiting
Phase 2
Doxycycline in Lymphanioleiomyomatosis (LAM): a randomised double blind placebo controlled crossover trial
Lymphangioleiomyomatosis
Dr.Deborah Yates30 enrolled1 locationACTRN12608000325303